Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olive leaf extract plus curcumin for external anogenital warts
IRCT20200509047350N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olive leaf extract and curcumin in anogenital warts, sponsored by Lorestan University of Medical Sciences. Primary endpoints: Improvement of clinical signs, Improvement of symptoms and 1 more. Started Jun 2020; status: completed.
02
Drugs
olive leaf extractcurcumin
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20200509047350N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200509047350N1.